✨ Free AI Report
OncoSec Medical Inc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview OncoSec Medical Inc
Research Preview

OncoSec Medical Inc: Business Overview, Financials & Competitive Analysis

OncoSec Medical is a late-stage immuno-oncology company that focuses on designing, developing, and commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the trea...

Analyst-debate audio for OncoSec Medical Inc

AskCyborg analysts argue the bull and bear cases for OncoSec Medical Inc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
OncoSec Medical Inc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

Clinical-stage immunotherapy company with differentiated electroporation-based drug delivery, but execution risk in late-stage...

Read the full analyst-debate transcript →
Industry Immuno-oncology gene therapies
3 named competitors
1 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest OncoSec Medical Inc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

OncoSec Medical Inc Overview

Pro stress-test →

OncoSec Medical is a late-stage immuno-oncology company that focuses on designing, developing, and commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company is a subsidiary of Grand Pharmaceutical Group Ltd.

Strategic Profile

Pro stress-test →

The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. The proprietary ImmunoPulse technology is designed to enhance local delivery and uptake of DNA-based therapeutics directly into tumors using electroporation, which involves the use of electrical pulses to increase the permeability of the cell membrane.

Competitive Landscape

Pro stress-test →

Top competitors include Jazz Pharmaceuticals, Alnylam, and Spark Therapeutics, which represent the broader immuno-oncology and gene therapy competitive landscape. OncoSec differentiates through its electroporation-based intratumoral delivery platform targeting localized tumoral immunity.

Industry Context

OncoSec Medical Inc operates in Immuno-oncology gene therapies.

Key facts

Founded: 2008 · Headquarters: San Diego, US · Employees: 41 · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for OncoSec Medical Inc.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when OncoSec Medical Inc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Oncology PipelineOncology and cell therapy programs→RNAi TherapeuticsGene therapy and RNA interference platform→Gene TherapyInherited retinal disease and genetic therapies→

Compare OncoSec Medical Inc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

OncoSec Medical Inc operates in Immuno-oncology gene therapies. See how the rest of the sector scores on the Cyborg framework.

Browse Immuno-oncology gene therapies research →
NEW · MCP server

Ask your AI assistant about OncoSec Medical Inc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare OncoSec Medical Inc and its top competitor on Cyborg Score”
“What did OncoSec Medical Inc do this quarter?”
“Is OncoSec Medical Inc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does OncoSec Medical Inc do?+
OncoSec Medical is a late-stage immuno-oncology company that focuses on designing, developing, and commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the trea...
What is OncoSec Medical Inc's Cyborg Score?+
OncoSec Medical Inc has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are OncoSec Medical Inc's main competitors?+
Named competitors include Oncology Pipeline, RNAi Therapeutics, Gene Therapy. The full competitive landscape is in the AskCyborg report.
How can I get the full OncoSec Medical Inc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the OncoSec Medical Inc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track OncoSec Medical Inc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9GELEX Group Joint Stock Company9TTM Technologies, Inc.9Insulet Corporation9Marathon Petroleum Corporation9Seagate Technology Holdings plc9Howmet Aerospace Inc.9Investor AB9Micron Technology, Inc.9Taiwan Semiconductor Manufacturing Company Limited9NVIDIA Corporation8NIO Inc.8Seanergy Maritime Holdings Corp.8Grupo Aeroméxico, S.A.B. de C.V.8Gulf Medical Projects Company8Interloop Limited8Kyverna Therapeutics, Inc.8Tatton Asset Management Plc8Invictus Investment Company PLC